Business Wire

METI will hold GGX x TCFD Summit

27.9.2023 15:35:00 EEST | Business Wire | Press release

Share

From 10:00 on October 2 (Mon.), the Ministry of Economy, Trade and Industry (METI) will hold the Global Green Transformation (GGX) Conference and the TCFD Summit, which until now have attracted participation from a wide range of sectors including global industry, finance, governments, regulators, and international organizations, will be held jointly. In order to further develop discussions on transition finance, avoided emissions, industry decarbonization, and other topics related to how business and finance contribute to decarbonization, the event will promote mutual cooperation between the government, business, and financial sectors, and hold discussions to lead the international rule-making process to achieve both emission reductions and economic growth.

  • Outline of Global Green Transformation (GGX) Conference and the TCFD Summit

Date: October 2nd, 2023 10:00-17:00 (JST)
Organizer: Ministry of Economy, Trade and Industry (METI)
Co-organizer: TCFD Consortium, The World Business Council for Sustainable Development (WBCSD)
Format: Hybrid (On-Site and On-Line)
Web Site: https://tcfd-summit.go.jp/indexEn.html

  • Online Registration

Online Registration Site: https://jcs.eventsair.com/ggxtcfd2023/attendeereg/Site/Register
*Registration deadline: Oct 1st (Sun.) (JST, GMT+9:00)

  • Program
  • Opening Remarks
    HATAKEYAMA Yojiro (Director-General, Industrial Science, Technology and Environment Policy Bureau, Ministry of Economy, Trade and Industry)
    TOKURA Masakazu (Chairman, Keidanren (Japan Business Federation))
    KATO Masahiko (Chairperson, Japanese Bankers Association)
    David Atkin (CEO, Principles for Responsible Investment (PRI))
  • Keynote Speech 1
    Gianluigi Benedetti (Ambassador, Embassy of Italy in Tokyo)
  • Panel Discussion 1 “Towards Net-Zero Society ~Industrial Decarbonisation~”
    What efforts are needed towards creating a "Green Market" to accelerate industrial decarbonization, focusing on the creation of demand?
    [Moderator]
    Peter Bakker (President and CEO, World Business Council for Sustainable Development (WBCSD))
    [Panelist]
    Nancy Gillis (Program Head, First Movers Coalition, World Economic Forum)
    Rana Ghoneim (Chief, Energy Systems and Industrial Decarbonization Unit, United Nations Industrial Development Organization)
    TEZUKA Hiroyuki (Fellow, Executive, JFE Steel Corporation)
    MITA Noriyuki (Vice President, Sustainability Department, Mitsubishi Chemical Group Corporation *After October 1st)
    KOBAYASHI Izuru (Deputy Director-General for Environmental Affairs, Ministry of Economy, Trade and Industry)
  • Panel Discussion 2 “Solution Provider and Avoided Emissions”
    Companies are increasingly expected to provide solutions to social challenges. What is the potential of the idea of "avoided emissions" to evaluate a company's contribution to decarbonization of the society as a whole by providing solutions?
    [Moderator]
    HAYASHI Reiko (Director and Deputy President, BofA Securities Japan Co., Ltd.)
    [Panelist]
    Jason Mortimer (Head of Sustainable Investment - Fixed Income, Investment Department - Global Solutions, Nomura Asset Management)
    UEHARA Hirotoshi (Executive Officer, Quality & Environment, CS, Panasonic Operational Excellence Co., Ltd.)
    HIRUTA Takako (Country Leader, CS&Q, Schneider Electric Japan, Inc)
  • Keynote Speech 3
    Emmanuel Faber (Chair, ISSB)
    MIYAZONO Masataka (President, Government Pension Investment Fund)
    MIZUNO Hiromichi (Founder And CEO, Good Steward Partners, LLC)
  • Panel Discussion 3 “Future of Climate-Related Financial Disclosures”
    As climate-related financial disclosures rapidly expand, what efforts are needed going forward? How can disclosure promote transition finance?
    [Moderator]
    NAGAMURA Masaaki (Fellow, International Initiatives, Tokio Marine Holdings, Inc.)
    [Panelist]
    Alex Michie (Head of Secretariat, GFANZ)
    IKEDA Satoshi (Chief Sustainable Finance Officer, Strategy Development And Management Bureau, Financial Services Agency)
    ISHIKAWA Tomohiro (Chief Regulatory Engagement Officer, Corporate Planning Division, Mitsubishi UFJ Financial Group (MUFG))
    KITAGAWA Keiko (General Manager, Sustainability Promotion Unit, Global Investor Relations Group, Finance Strategy and Planning Division, JERA Co., Inc.)
  • Keynote Speech 4
    Mary Schapiro (Head, The TCFD Secretariat)
    ITO Kunio (Chair, The TCFD Consortium)
  • Panel Discussion 4 “Further Promotion of Transition Finance”
    As the understanding of the importance of transition finance grows globally, what efforts are needed to further promote investments toward decarbonization of corporates and the private financing towards them?
    [Moderator]
    KIHARA Shinichi (Director General for International Policy on Carbon Neutrality, Ministry of Economy, Trade and Industry)
    [Panelist]
    Nicholas Pfaff (Deputy Chief Executive, Head of Sustainable Finance, International Capital Market Association)
    Sean Kidney (CEO, Climate Bonds Initiative)
    Eila Kreivi (Director, Chief Sustainable Finance Advisor, Secretariat General, European Investment Bank)
    KUBOTA Nobuhiko (Managing Executive Officer, General Manager of Technology & Intelligence Integration, IHI Corporation)
  • Closing Remarks
    Peter Bakker (President and CEO, World Business Council for Sustainable Development (WBCSD))

*The above programs and speakers may be subject to change at the discretion of the organizer.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contact information for inquiries
GGX x TCFD Summit 2023 Registration Desk
E-mail: ggxtcfd2023-reg@convention.co.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release

Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye